343 related articles for article (PubMed ID: 23647674)
1. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel.
Chen X; Zhi F; Jia X; Zhang X; Ambardekar R; Meng Z; Paradkar AR; Hu Y; Yang Y
J Pharm Pharmacol; 2013 Jun; 65(6):807-16. PubMed ID: 23647674
[TBL] [Abstract][Full Text] [Related]
2. Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan.
Li C; Li C; Liu Z; Li Q; Yan X; Liu Y; Lu W
Int J Pharm; 2014 Oct; 474(1-2):123-33. PubMed ID: 25138250
[TBL] [Abstract][Full Text] [Related]
3. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine.
Qian S; Wong YC; Zuo Z
Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
5. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
Ved PM; Kim K
Int J Pharm; 2011 Jun; 411(1-2):1-9. PubMed ID: 21356294
[TBL] [Abstract][Full Text] [Related]
6. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
Shinde RL; Bharkad GP; Devarajan PV
Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
[TBL] [Abstract][Full Text] [Related]
7. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
Mura P; Mennini N; Nativi C; Richichi B
Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
[TBL] [Abstract][Full Text] [Related]
8. The Controlled Release and Anti-Inflammatory Activity of a Tetramethylpyrazine-Loaded Thermosensitive Poloxamer Hydrogel.
Xia H; Jin H; Cheng Y; Cheng Z; Xu Y
Pharm Res; 2019 Feb; 36(4):52. PubMed ID: 30783816
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin.
Wang S; Chen P; Zhang L; Yang C; Zhai G
J Drug Target; 2012 Dec; 20(10):831-40. PubMed ID: 22934854
[TBL] [Abstract][Full Text] [Related]
10. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administration].
Tao T; Zhao Y; Yue P; Dong WX; Chen QH
Yao Xue Xue Bao; 2006 Nov; 41(11):1104-10. PubMed ID: 17262956
[TBL] [Abstract][Full Text] [Related]
12. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
Li XY; Zhu ZJ; Cheng AY
Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
[TBL] [Abstract][Full Text] [Related]
14. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting.
Jose S; Ansa CR; Cinu TA; Chacko AJ; Aleykutty NA; Ferreira SV; Souto EB
Int J Pharm; 2013 Jan; 441(1-2):516-26. PubMed ID: 23147411
[TBL] [Abstract][Full Text] [Related]
15. Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route.
Jain DS; Bajaj AN; Athawale RB; Shikhande SS; Pandey A; Goel PN; Gude RP; Patil S; Raut P
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():411-21. PubMed ID: 27040235
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
Shi S; Wu J; Dai W; Li C; Ge W
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
[TBL] [Abstract][Full Text] [Related]
17. Hydrophilic nasal gel of lidocaine hydrochloride. 2nd communication: Improved bioavailability and brain delivery in rats with low ciliotoxicity.
Hu KL; Mei N; Feng L; Jiang XG
Arzneimittelforschung; 2009; 59(12):635-40. PubMed ID: 20108649
[TBL] [Abstract][Full Text] [Related]
18. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
[TBL] [Abstract][Full Text] [Related]
19. Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats.
Zhao Y; Yue P; Tao T; Chen QH
Acta Pharmacol Sin; 2007 Feb; 28(2):273-8. PubMed ID: 17241531
[TBL] [Abstract][Full Text] [Related]
20. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
